First-ever phase-three clinical trial for dengue vaccine initiated in India
[ad_1] India’s indigenous tetravalent dengue vaccine, DengiAll, has been developed by Panacea Biotec and the first participant in this trial was vaccinated on Wednesday at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, as per a Health Ministry statement | Photo Credit: Getty Images/iStockphoto The Indian Council of Medical Research (ICMR)…